<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04299984</url>
  </required_header>
  <id_info>
    <org_study_id>iConveRt</org_study_id>
    <nct_id>NCT04299984</nct_id>
  </id_info>
  <brief_title>Italian Multicenter Database for Open Conversions After EVAR</brief_title>
  <acronym>iConveRt</acronym>
  <official_title>Italian Multicenter Prospective Database for Open Conversions and SemiConversions After Endovascular Aneurysm Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria di Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria di Parma</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Late endovascular abdominal aneurysm repair (EVAR) complications not amenable to endovascular
      correction can undergo either late open conversion (LOC) or semi-conversion (SC).

      LOC is defined as a total or partial endograft explantation &gt;30 days after the initial EVAR.

      SC is defined as open or laparoscopic surgery for endoleak (EL) correction with complete
      endograft preservation.

      The aim of this study is to collect in a prospective database the technical aspects of a
      multicenter experience of LOC and SC, and to analyse early and long-term outcomes of these
      two treatments.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2029</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Early Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>30-day mortality after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In-hospital Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Mortality during in-hospital stay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term survival</measure>
    <time_frame>4 years</time_frame>
    <description>Long-term survival rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early Morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>Major complications after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Related complications</measure>
    <time_frame>4 years</time_frame>
    <description>Aorta-related complications during follow-up</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <condition>Abdominal Aortic Aneurysm Enlargement</condition>
  <arm_group>
    <arm_group_label>Open Conversions</arm_group_label>
    <description>Patients undergoing total or partial endograft explantation for any EVAR complication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SemiConversions</arm_group_label>
    <description>Patients undergoing open or laparoscopic surgery for any EVAR complication (mostly endoleak correction) with complete endograft preservation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Conversion after EVAR</intervention_name>
    <description>See &quot;Open Conversions&quot; group description.</description>
    <arm_group_label>Open Conversions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SemiConversion after EVAR</intervention_name>
    <description>See &quot;SemiConversions&quot; group description.</description>
    <arm_group_label>SemiConversions</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent EVAR for abdominal aortic aneurysm exclusion, who developed
        complications not amenable to endovascular repair.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  open or laparoscopic surgery for EVAR complications, with or without endograft
             explantation

        Exclusion Criteria:

          -  endovascular reinterventions

          -  extra-anatomical bypass surgery (e.g. femoro-femoral crossover bypass) not associated
             with direct aorta/endograft surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Perini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Parma Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo Perini, MD</last_name>
    <phone>+390521702349</phone>
    <email>p.perini@live.com</email>
  </overall_contact>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 5, 2020</study_first_submitted>
  <study_first_submitted_qc>March 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria di Parma</investigator_affiliation>
    <investigator_full_name>Paolo Perini</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>Open surgical conversion</keyword>
  <keyword>Endovascular repair</keyword>
  <keyword>EVAR explantation</keyword>
  <keyword>Failed EVAR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

